author-photo

Antonio Tito Fojo

National Institutes of Health

147

Papers

12774

Citations

Citation Trend

Filter By

Papers (108) Sort By

Journal Conference Others

A Medical Pearl Harbor: Pandemic Uncovers Societal Fissures and Leadership Breaches

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-003: OncoMatch: Unbiased, quantitative assessment of cancer model fidelity for drug sensitivity and mechanism of action elucidation

2020
Show All
- Source
- Cite
- Save
Citations (0)
Correlation between innate cytokine levels and progression in men with biochemically recurrent prostate cancer treated with intermittent hormonal therapy.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Role of radiomics to differentiate benign from malignant pheochromocytomas and paragangliomas on contrast enhanced CT scans.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Cisplatin (CIS) versus cetuximab (CET) with definitive concurrent radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC): An analysis of veteran’s health data.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A novel approach to mine the Veterans Administration Informatics and Computing Infrastructure (VINCI) allows one to assess the efficacy of cancer therapies: Abiraterone and enzalutamide in Veterans with metastatic prostate cancer (PC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Tumor growth and regression rate constants from the CLARINET study as surrogate endpoints for progression free survival: A novel assessment approach in cancer therapy.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Early response metrics for predicting trial outcomes: A report from volumetric CT for precision analysis of clinical trials (Vol-PACT).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Targeted agents (TA) for advanced solid tumors (AST): What is the likelihood of being helped or harmed (LHH)? Assessing the clinical impact of therapies with FDA/EMEA approval.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Two decades of therapy in metastatic colorectal cancer (mCRC): An analysis to discern the contribution and progress made by chemotherapy.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)